Dimethylformamide → 2-Butyl-4-chloro-5-(3-chlorophenyl)isothiazol-3(2H)-one 1,1-dioxide
Reaction equation
CN(C=O)C.[CH2:6]([N:10]1[C:14](=[O:15])[C:13](O)=[C:12]([C:17]2[CH:22]=[CH:21][CH:20]=[C:19]([Cl:23])[CH:18]=2)[S:11]1(=[O:25])=[O:24])[CH2:7][CH2:8][CH3:9].C(Cl)(=O)C([Cl:29])=O>C(Cl)Cl>[CH2:6]([N:10]1[C:14](=[O:15])[C:13]([Cl:29])=[C:12]([C:17]2[CH:22]=[CH:21][CH:20]=[C:19]([Cl:23])[CH:18]=2)[S:11]1(=[O:25])=[O:24])[CH2:7][CH2:8][CH3:9]Participants
Procedure
Dry DMF (0.17 mL, 2.21 mmol) was added to a solution of 2-butyl-5-(3-chlorophenyl)-4-hydroxyisothiazol-3(2H)-one 1,1-dioxide (697 mg, 2.21 mmol) in dry DCM (15 mL) at rt and under an atmosphere of nitrogen. Oxalyl chloride (0.37 mL, 4.41 mmol) was added dropwise and the mixture was heated to reflux for 2.5 h. The reaction mixture was evaporated to dryness. The residue was dissolved in EtOAc and it was washed with several portions of water, dried with MgSO4, and evaporated to give the title compound (685 mg, 84%) as a brown oil which was used without further purification; 1H NMR (500 MHz, CDCl3): δ 7.96 (t, 1H), 7.84-7.88 (m, 1H), 7.57-7.61 (m, 1H), 7.50-7.55 (t, 1H), 3.79 (t, 2H), 1.80-1.87 (m, 2H), 1.39-1.51 (m, 2H), 1.00 (t, 3H); 13C NMR (125 MHz, CDCl3): δ 161.5, 155.9, 142.4, 135.8, 132.8, 131.0, 129.0, 127.3, 125.1, 41.0, 30.4, 20.1, 13.7.
Workup
- temperaturethe mixture was heated
- temperatureto reflux for 2.5 h
- customThe reaction mixture was evaporated to dryness
- dissolutionThe residue was dissolved in EtOAc
- washit was washed with several portions of water
- dry with materialdried with MgSO4
- customevaporated
Sources & evidence
- ORD record
- ord-1ac7ccacb6d04ebdb4c16d45345a8343
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07582629B2
Reaction notes
Loading…